Seacross Pharmaceutical Co Ltd | Sichuan Huiyu Pharmaceuticals Co., Ltd. - Formulation Manufacturing Site

The Formulation Manufacturing Site features 15 advanced production lines capable of handling vial sizes from 2 mL to 100 mL, with preparation tanks ranging from 3 L to 5,000 L. The facility is designed to safely and efficiently manufacture high-potency (OEB5), oncology, cytotoxic, and hormonal products, ensuring compliance with the highest standards of safety and quality.

The site offers a broad range of technology platforms, including:

• Long-acting implants
• Microspheres
• Nanocrystals/nanoparticles
• Liposomes
• Albumin-bound formulations
• Injectable gels

It supports multiple injectable dosage forms such as:

• Pre-filled syringes
• Injection pens
• Cartridges
• Vials

The facility also provides a full suite of manufacturing capabilities, including:

• Aseptic filling
• Terminal sterilization
• Sterile powder filling
• Lyophilization (freeze-drying)
• Oral solid dosage production (tablets, capsules)

The site operates in compliance with major global regulatory standards and has been approved by health authorities including China NMPA, US FDA, UK MHRA, EU EMA, Japan PMDA, Korea MFDS, South Africa SAHPRA, Portugal Infarmed, and Finland Fimea, among others.